PAPER Hu Y, Li C, Shen W
SEARCH RESULTS
330907 RESULTS
PAPER Ferencz B, Laukka EJ, Welmer AK, Kalpouzos G, Angleman S, Keller L, Graff C, Lövdén M, Bäckman L
The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning.
Psychol Aging. 2014 Jun;29(2):440-9. Epub 2014 Mar 24 PubMed: 24660791PAPER Diwu Y, Tian J, Shi J
Effect of Xixin decoction on phosphorylation toxicity at specific sites of tau protein in brains of rats with sporadic Alzheimer disease.
J Tradit Chin Med. 2013 Dec;33(6):787-93. PubMed: 24660612PAPER Burrell JR, Hornberger M, Vucic S, Kiernan MC, Hodges JR
Apraxia and motor dysfunction in corticobasal syndrome.
PLoS One. 2014;9(3):e92944. Epub 2014 Mar 24 PubMed: 24664085PAPER
Summaries for patients. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014 Jun 3;160(11) PubMed: 24663960PAPER Moyer VA, U.S. Preventive Services Task Force
Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014 Jun 3;160(11):791-7. PubMed: 24663815PAPER Disbrow EA, Carmichael O, He J, Lanni KE, Dressler EM, Zhang L, Malhado-Chang N, Sigvardt KA
Resting State Functional Connectivity is Associated with Cognitive Dysfunction in Non-Demented People with Parkinson's Disease.
J Parkinsons Dis. 2014 Jan 1;4(3):453-65. PubMed: 24662193PAPER Pedrosa DJ, Auth M, Pauls KA, Runge M, Maarouf M, Fink GR, Timmermann L
Verbal fluency in essential tremor patients: the effects of deep brain stimulation.
Brain Stimul. 2014 May-Jun;7(3):359-64. Epub 2014 Feb 28 PubMed: 24661791PAPER Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH
The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Eur J Neurol. 2014 Jun;21(6):922-e50. Epub 2014 Mar 24 PubMed: 24661277PAPER Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
JAMA Neurol. 2014 May;71(5):543-52. PubMed: 24664227PAPER Arkadir D, Bergman H, Fahn S
Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease.
Neurology. 2014 Mar 25;82(12):1093-8. PubMed: 24663231PAPER
Neurodegenerative disease: Potential adverse effects of histone deactylase inhibition in spinocerebellar ataxia type 1.
Nat Rev Neurol. 2014 Apr;10(4) Epub 2014 Mar 25 PubMed: 24662532PAPER Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Kahan J, Fmedsci PE, Whitton P, Wyse R, Isaacs T, Lees A, Limousin P, Foltynie T
Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson's Disease.
J Parkinsons Dis. 2014 Mar 24; PubMed: 24662192PAPER Ishikawa KI, Motoi Y, Mizuno Y, Kubo SI, Hattori N
Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
Psychogeriatrics. 2014 Mar 24; PubMed: 24661498PAPER Cipriani G, Lucetti C, Nuti A, Danti S
Wandering and dementia.
Psychogeriatrics. 2014 Mar 24; PubMed: 24661471Current Filters
No filters selected